A Biobehavioral Home-Based Intervention and the Well-being of Patients With Dementia and Their Caregivers The COPE Randomized Trial

Jefferson Center for Applied Research on Aging and Health, Thomas Jefferson University, 130 S Ninth St, Ste 513, Philadelphia, PA 19130, USA.
JAMA The Journal of the American Medical Association (Impact Factor: 35.29). 09/2010; 304(9):983-91. DOI: 10.1001/jama.2010.1253
Source: PubMed


Optimal treatment to postpone functional decline in patients with dementia is not established.
To test a nonpharmacologic intervention realigning environmental demands with patient capabilities.
Prospective 2-group randomized trial (Care of Persons with Dementia in their Environments [COPE]) involving patients with dementia and family caregivers (community-living dyads) recruited from March 2006 through June 2008 in Pennsylvania.
Up to 12 home or telephone contacts over 4 months by health professionals who assessed patient capabilities and deficits; obtained blood and urine samples; and trained families in home safety, simplifying tasks, and stress reduction. Control group caregivers received 3 telephone calls and educational materials.
Functional dependence, quality of life, frequency of agitated behaviors, and engagement for patients and well-being, confidence using activities, and perceived benefits for caregivers at 4 months.
Of 284 dyads screened, 270 (95%) were eligible and 237 (88%) randomized. Data were collected from 209 dyads (88%) at 4 months and 173 (73%) at 9 months. At 4 months, compared with controls, COPE patients had less functional dependence (adjusted mean difference, 0.24; 95% CI, 0.03-0.44; P = .02; Cohen d = 0.21) and less dependence in instrumental activities of daily living (adjusted mean difference, 0.32; 95% CI, 0.09-0.55; P = .007; Cohen d = 0.43), measured by a 15-item scale modeled after the Functional Independence Measure; COPE patients also had improved engagement (adjusted mean difference, 0.12; 95% CI, 0.07-0.22; P = .03; Cohen d = 0.26), measured by a 5-item scale. COPE caregivers improved in their well-being (adjusted mean difference in Perceived Change Index, 0.22; 95% CI, 0.08-0.36; P = .002; Cohen d = 0.30) and confidence using activities (adjusted mean difference, 0.81; 95% CI, 0.30-1.32; P = .002; Cohen d = 0.54), measured by a 5-item scale. By 4 months, 64 COPE dyads (62.7%) vs 48 control group dyads (44.9%) eliminated 1 or more caregiver-identified problems (chi(2/1) = 6.72, P = . 01).
Among community-living dyads, a nonpharmacologic biobehavioral environmental intervention compared with control resulted in better outcomes for COPE dyads at 4 months. Although no group differences were observed at 9 months for patients, COPE caregivers perceived greater benefits. Identifier: NCT00259454.

Download full-text


Available from: Laura N Gitlin
    • "Environmental adaptations can be helpful to individuals with functional challenges in a wide range of settings (e.g., home, community-based centers) including hospitals (e.g., special care units), assisted living and nursing home facilities, and for individuals with varying health and functional challenges including cognitive loss, physical limitations, or sensory changes. Individuals with cognitive impairment may benefit from adaptations involving simple changes in the living environment and ways of performing everyday tasks (Gitlin et al. 2003; Gitlin et al. 2010b). Examples of useful adaptations for individuals with cognitive impairment may include , but are not limited to, memory boards, labeling or use of other visual cues including color coding, and removal of clutter or unnecessary objects to promote way finding in specified areas in which particular tasks are performed (e.g., eating at the kitchen table). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Environmental adaptation is an important intervention to help individuals with disabilities remain at home independently and ease the burden of care on their families. A range of adaptations can be considered, including removing or rearranging objects, special equipment, and adaptive tools. Providing an environ-mental adaptation involves assessment of a person’s needs and capabilities and the environment’s physical and social properties, choosing an adaptation, ordering and installing it, and training the individual and family member in its use. This chapterprovides an overview of environmental adaptation as an intervention for the elderly, clinicalprinciples, and the evidence to support this approach.
    No preview · Article · Jan 2015
    • "REACH-Memphis, 2003 (204) REACH-Philadelphia, 2003 (204) Teri et al, 2005 (41) Gitlin et al, 2010 (207) Martin-Carrasco et al, 2009 (213) Wright et al, 2001 (220) "
    [Show abstract] [Hide abstract]
    ABSTRACT: Earlier identification of cognitive impairment may reduce patient and caregiver morbidity. To systematically review the diagnostic accuracy of brief cognitive screening instruments and the benefits and harms of pharmacologic and nonpharmacologic interventions for early cognitive impairment. MEDLINE, PsycINFO, and the Cochrane Central Register of Controlled Trials through December 2012; systematic reviews; clinical trial registries; and experts. English-language studies of fair to good quality, primary care-feasible screening instruments, and treatments aimed at persons with mild cognitive impairment or mild to moderate dementia. Dual quality assessment and abstraction of relevant study details. The Mini-Mental State Examination (k = 25) is the most thoroughly studied instrument but is not available for use without cost. Publicly available instruments with adequate test performance to detect dementia include the Clock Drawing Test (k = 7), Mini-Cog (k = 4), Memory Impairment Screen (k = 5), Abbreviated Mental Test (k = 4), Short Portable Mental Status Questionnaire (k = 4), Free and Cued Selective Reminding Test (k = 2), 7-Minute Screen (k = 2), and Informant Questionnaire on Cognitive Decline in the Elderly (k = 5). Medications approved by the U.S. Food and Drug Administration for Alzheimer disease (k = 58) and caregiver interventions (k = 59) show a small benefit of uncertain clinical importance for patients and their caregivers. Small benefits are also limited by common adverse effects of acetylcholinesterase inhibitors and limited availability of complex caregiver interventions. Although promising, cognitive stimulation (k = 6) and exercise (k = 10) have limited evidence to support their use in persons with mild to moderate dementia or mild cognitive impairment. Limited studies in persons with dementia other than Alzheimer disease and sparse reporting of important health outcomes. Brief instruments to screen for cognitive impairment can adequately detect dementia, but there is no empirical evidence that screening improves decision making. Whether interventions for patients or their caregivers have a clinically significant effect in persons with earlier detected cognitive impairment is still unclear. Agency for Healthcare Research and Quality.
    No preview · Article · Oct 2013 · Annals of internal medicine
  • Source
    • "Some studies16,17 have had well trained staff educate family members either by performing family visits or making telephone contact. Other studies18,19 have directly trained health professionals, such as assisted living residence or care staff in nursing or residential homes, to develop skills in behavioral management. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Agitated behaviors are frequently observed in patients with dementia and can cause severe distress to caregivers. However, little evidence of the efficacy of nonpharmacological interventions for agitated behaviors exists for patients with dementia. The present pilot study aimed to evaluate a behavioral management program developed by the Seattle Protocols for patients with agitated behaviors in Japan. Eighteen patients with dementia (Alzheimer's disease, n = 14; dementia with Lewy bodies, n = 4) participated in an open study testing the effectiveness of a behavioral management program. The intervention consisted of 20 sessions over the course of 3 months. The primary outcomes were severity of agitation in dementia, as measured using the Agitated Behavior in Dementia scale (ABID) and the Cohen-Mansfield Agitation Inventory (CMAI). The behavioral management program resulted in significant reductions in total scores on both the ABID and CMAI. Although both physically agitated and verbally agitated behavior scores on the ABID improved significantly, symptoms of psychosis did not improve after the intervention. The behavioral management technique may be beneficial to distressed caregivers of patients with dementia. In the future, a well designed study to develop the behavioral management program more fully is needed.
    Full-text · Article · Jan 2013 · Neuropsychiatric Disease and Treatment
Show more